Fast-growing vaccine developer doubles San Carlos headquarters
| IMCR Stock | USD 32.74 0.09 0.27% |
Slightly above 54% of Immunocore Holdings' investor base is interested to short. The analysis of the overall investor sentiment regarding Immunocore Holdings suggests that many traders are impartial. Immunocore Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Immunocore Holdings. Many technical investors use Immunocore Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immunocore |
Vaxcyte more than doubled its headquarters space at the Alexandria Center for Life Science in San Carlos, pictured, in its latest expansion there.
Read at bizjournals.com
 |
Immunocore Holdings Current Investor Sentiment
Panic Vs Confidence
46
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Immunocore Holdings' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Immunocore Holdings.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
Immunocore Holdings Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Immunocore Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Immunocore Holdings Fundamental Analysis
We analyze Immunocore Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunocore Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunocore Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Immunocore Holdings is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Immunocore Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunocore Holdings stock to make a market-neutral strategy. Peer analysis of Immunocore Holdings could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics with similar companies.
Peers
Immunocore Holdings Related Equities
| GLUE | Monte Rosa | 13.72 | ||||
| LYRA | Lyra Therapeutics | 10.53 | ||||
| VTYX | Ventyx Biosciences | 1.13 | ||||
| DSGN | Design Therapeutics | 0.50 | ||||
| PCVX | Vaxcyte | 0.38 | ||||
| NUVL | Nuvalent | 0.08 | ||||
| KALV | Kalvista Pharmaceuticals | 0.30 | ||||
| MIRM | Mirum Pharmaceuticals | 0.92 | ||||
| ACLX | Arcellx | 1.12 | ||||
| VRDN | Viridian Therapeutics | 1.46 | ||||
| ERAS | Erasca | 2.05 | ||||
| LRMR | Larimar Therapeutics | 4.67 |
Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.